EMD-60110

Single-particle
3.54 Å
EMD-60110
3D View Gallery
Deposition: 11/05/2024
Map released: 21/08/2024
Last modified: 16/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-60110
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8zho summary report (pdf.gz) Map and 8zho FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 S1 in complex with H18 and R1-32 Fab

EMD-60110

Single-particle
3.54 Å
EMD-60110
3D View Gallery
Deposition: 11/05/2024
Map released: 21/08/2024
Last modified: 16/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 S1 in complex with H18 and R1-32 Fab
Fitted models: 8zho

Deposition Authors: Yan Q , Gao X , Liu B, Hou R, He P, Li Z, Chen Q, Wang J, He J , Chen L , Zhao J , Xiong X
Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants.
Yan Q , Gao X , Liu B, Hou R, He P, Ma Y, Zhang Y, Zhang Y, Li Z, Chen Q, Wang J, Huang X, Liang H, Zheng H, Yao Y, Chen X, Niu X, He J , Chen L , Zhao J , Xiong X
(2024) Nat Commun , 15 , 7585 - 7585
PUBMED: 39217172
DOI: doi:10.1038/s41467-024-51770-3
ISSN: 2041-1723